| Autor: |
Xiao-Long Li, Jia-Xin Li, Song-Yuan Yu, Pei-Li Fan, Yun-Jie Jin, Er-Jiao Xu, Sai-Nan Guan, Er-Ya Deng, Qiu-Yan Li, Zheng-Biao Ji, Jiu-Ling Qi, Hui-Xiong Xu |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Ultrasonography, Vol 43, Iss 1, Pp 68-77 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2288-5943 |
| DOI: |
10.14366/usg.23145 |
| Popis: |
Purpose This study evaluated the value of contrast-enhanced ultrasonography (CEUS) in the ultrasound-guided microwave ablation (MWA) treatment of symptomatic focal uterine adenomyosis. Methods This retrospective study was conducted between March 2020 and January 2023, enrolling 52 patients with symptomatic focal uterine adenomyosis who had undergone MWA. All patients were examined with CEUS before and after MWA. The non-perfused volume (NPV) was compared between CEUS and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) following ablation. Therapeutic efficacy and safety were evaluated at 3-, 6-, and 12-month follow-ups. Additionally, this study explored the correlations between pre-treatment CEUS features and a volume reduction ratio indicating sufficient ablation, defined as 50% or more at the 3-month follow-up. Results No significant differences in NPV were noted between CEUS and DCE-MRI immediately after MWA and during follow-up (all P>0.05). At the 3-month follow-up, the median VRRs for the uterus and adenomyosis were 33.2% and 63.9%, respectively. Sufficient ablation was achieved in 69.2% (36/52) of adenomyosis cases, while partial ablation was observed in the remaining 30.8% (16/52). The identification of non-enhancing areas on pre-treatment CEUS was associated with sufficient ablation (P=0.016). At the 12-month follow-up, significant decreases were observed in both the uterine and adenomyosis volumes (all P |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
